FGF10 Therapeutic Administration Promotes Mobilization of Injury-Activated Alveolar Progenitors in a Mouse Fibrosis Model

FGF10 Therapeutic Administration Promotes Mobilization of Injury-Activated Alveolar Progenitors in a Mouse Fibrosis Model

Idiopathic pulmonary fibrosis (IPF) is a devastating interstitial lung disease with dire consequences and in urgent need of improved therapies. Compelling evidence indicates that damage or dysfunction of AT2s is of central importance in the development of IPF. We recently identified a novel AT2 subp...

Full description

Bibliographic Details
Main Authors: Yu-Qing Lv, Ge-Fu Cai, Ping-Ping Zeng, Qhaweni Dhlamini, Le-Fu Chen, Jun-Jie Chen, Han-Deng Lyu, Majid Mossahebi-Mohammadi, Negah Ahmadvand, Saverio Bellusci, Xiaokun Li, Chengshui Chen, Jin-San Zhang
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Cells
Subjects:
pulmonary fibrosis
bleomycin
recombinant FGF10
alveolar epithelial progenitors
AT2 cells
Online Access:https://www.mdpi.com/2073-4409/11/15/2396

Internet

https://www.mdpi.com/2073-4409/11/15/2396

Similar Items